These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22453057)

  • 41. Descriptive study on the efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Sudan.
    Elamin SB; Awad AI; Eltayeb IB; Elmardi KA; Hassan AH; Mohamed AO; Malik EM; Mohamad TA
    Eur J Clin Pharmacol; 2010 Mar; 66(3):231-7. PubMed ID: 20187287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacovigilance of artemether-lumefantrine in pregnant women followed until delivery in Rwanda.
    Rulisa S; Kaligirwa N; Agaba S; Karema C; Mens PF; de Vries PJ
    Malar J; 2012 Jul; 11():225. PubMed ID: 22770264
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children.
    Katrak S; Gasasira A; Arinaitwe E; Kakuru A; Wanzira H; Bigira V; Sandison TG; Homsy J; Tappero JW; Kamya MR; Dorsey G
    Malar J; 2009 Nov; 8():272. PubMed ID: 19948038
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria.
    Vugt MV; Wilairatana P; Gemperli B; Gathmann I; Phaipun L; Brockman A; Luxemburger C; White NJ; Nosten F; Looareesuwan S
    Am J Trop Med Hyg; 1999 Jun; 60(6):936-42. PubMed ID: 10403324
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.
    Lefèvre G; Looareesuwan S; Treeprasertsuk S; Krudsood S; Silachamroon U; Gathmann I; Mull R; Bakshi R
    Am J Trop Med Hyg; 2001; 64(5-6):247-56. PubMed ID: 11463111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Artemether-lumefantrine: an option for malaria.
    Stover KR; King ST; Robinson J
    Ann Pharmacother; 2012 Apr; 46(4):567-77. PubMed ID: 22496476
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children.
    Sowunmi A; Akano K; Ayede AI; Ntadom G; Fatunmbi B; Aderoyeje T; Adewoye EO
    BMC Infect Dis; 2015 Oct; 15():454. PubMed ID: 26502714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
    Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
    Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia.
    Hwang J; Alemayehu BH; Hoos D; Melaku Z; Tekleyohannes SG; Teshi T; Birhanu SG; Demeke L; Gobena K; Kassa M; Jima D; Reithinger R; Nettey H; Green M; Malone JL; Kachur SP; Filler S
    Malar J; 2011 Jul; 10():209. PubMed ID: 21798054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Artemether-lumefantrine (Coartem) for treatment of malaria.
    Med Lett Drugs Ther; 2009 Sep; 51(1321):75-6. PubMed ID: 19763049
    [No Abstract]   [Full Text] [Related]  

  • 52. Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children.
    Maiteki-Sebuguzi C; Jagannathan P; Yau VM; Clark TD; Njama-Meya D; Nzarubara B; Talisuna AO; Kamya MR; Rosenthal PJ; Dorsey G; Staedke SG
    Malar J; 2008 Jun; 7():106. PubMed ID: 18547415
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study.
    Poirot E; Soble A; Ntshalintshali N; Mwandemele A; Mkhonta N; Malambe C; Vilakati S; Pan S; Darteh S; Maphalala G; Brown J; Hwang J; Pace C; Stergachis A; Vittinghoff E; Kunene S; Gosling R
    Malar J; 2016 Jul; 15(1):384. PubMed ID: 27450652
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety and efficacy of artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Ethiopia.
    Jima D; Tesfaye G; Medhin A; Kebede A; Argaw D; Babaniyi O
    East Afr Med J; 2005 Aug; 82(8):387-90. PubMed ID: 16261913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up.
    Adjei GO; Kurtzhals JA; Rodrigues OP; Alifrangis M; Hoegberg LC; Kitcher ED; Badoe EV; Lamptey R; Goka BQ
    Malar J; 2008 Jul; 7():127. PubMed ID: 18620577
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania.
    Kabanywanyi AM; Mwita A; Sumari D; Mandike R; Mugittu K; Abdulla S
    Malar J; 2007 Nov; 6():146. PubMed ID: 17996121
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Electrocardiographic study in Ghanaian children with uncomplicated malaria, treated with artesunate-amodiaquine or artemether-lumefantrine.
    Adjei GO; Oduro-Boatey C; Rodrigues OP; Hoegberg LC; Alifrangis M; Kurtzhals JA; Goka BQ
    Malar J; 2012 Dec; 11():420. PubMed ID: 23244570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children <5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial.
    Ngasala BE; Malmberg M; Carlsson AM; Ferreira PE; Petzold MG; Blessborn D; Bergqvist Y; Gil JP; Premji Z; Björkman A; Mårtensson A
    Clin Infect Dis; 2011 Apr; 52(7):873-82. PubMed ID: 21427394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults.
    Mulenga M; VangGeertruyden JP; Mwananyanda L; Chalwe V; Moerman F; Chilengi R; Van Overmeir C; Dujardin JC; D'Alessandro U
    Malar J; 2006 Aug; 5():73. PubMed ID: 16923176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.